Target intelligence / Profile preview

Mitochondrial energy production

Molecular classification
Other
01

Overview

Mitochondrial energy production" is not a specific molecule, receptor, or protein but rather refers to the collective biochemical processes by which mitochondria generate adenosine triphosphate (ATP), the primary energy currency of the cell. This process primarily involves oxidative phosphorylation and the citric acid cycle (Krebs cycle), which occur within specialized compartments of mitochondria. The inner mitochondrial membrane houses key protein complexes that form the electron transport chain and ATP synthase, driving ATP generation through a proton gradient[1][3][4][5]. In addition to producing most of a cell’s ATP, mitochondria are involved in regulating apoptosis (programmed cell death), calcium homeostasis, and intermediary metabolism[1][2][4]. Dysfunction in mitochondrial energy production is implicated in various diseases including neurodegenerative disorders, cancer, cardiovascular conditions, and inherited metabolic syndromes[1][6]. Note on target status and correctness: "Mitochondrial energy production" does not refer to a single molecular entity such as an enzyme or receptor; it describes an essential cellular function carried out by multiple proteins and complexes within mitochondria. Therefore, it is not considered a canonical therapeutic target itself but rather an umbrella term for several potential targets involved in this process. For structured data purposes—such as drug discovery databases—a more precise molecular target should be specified (e.g., "ATP synthase," "Complex I," "Cytochrome c oxidase") instead of this general term.

02

Biological functions

Energy conversionATP synthesisOxidative phosphorylationCellular metabolismApoptosis regulationCalcium storage
03

Disease associations

Neurodegenerative diseaseCancerCardiovascular diseaseMetabolic disorders
04

Safety considerations

Mitochondrial toxicity (as seen with some drugs, e.g., certain antivirals or chemotherapeutics)Off-target effects leading to impaired cellular energy metabolism
05

Biomarkers

Mitochondrial DNA mutations (for mitochondrial diseases)ATP/ADP ratio (as a functional readout)

Beyond the preview

Go deeper on Mitochondrial energy production.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial energy production.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call